Shizuko Yoda
University of Wisconsin-Madison
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Shizuko Yoda.
Biochimica et Biophysica Acta | 1984
Atsunobu Yoda; Allen W. Clark; Shizuko Yoda
Membranous (Na+ + K+)-ATPase from the electric eel was solubilized with 3-[3-cholamidopropyl)-dimethylammonio)-1-propanesulfonate (Chaps). 50 to 70% of the solubilized enzyme was reconstituted in egg phospholipid liposomes containing cholesterol by using Chaps. The obtained proteoliposomes consisted of large vesicles with a diameter of 134 +/- 24 nm as the major component, and their protein/lipid ratio was 1.25 +/- 0.07 g protein/mol phospholipid. The intravesicular volume of these proteoliposomes is too small to consistently sustain the intravesicular concentrations of ligands, especially K+, during the assay. The decrease in K+ concentration was cancelled by the addition of 20 microM valinomycin in the assay medium. The low value of the protein/lipid ratio suggests that these proteoliposomes contain one Na+/K+-pump particle with a molecular mass of 280 kDa per one vesicle as the major component. In these proteoliposomes, the specific activity of the (Na+ + K+)-ATPase reaction was 10 mumol Pi/mg protein per min, and the turnover rate of the ATP-hydrolysis was 3500 min-1, the same as the original enzyme under the same assay condition. The ratio of transported Na+ to hydrolyzed ATP was 3, the same as that in the red cell. The proteoliposomes could be disintegrated by 40-50 mM Chaps without any significant inactivation. This disintegration of proteoliposomes nearly tripled the ATPase activity compared to the original ones and doubled the specific ATPase activity compared to the membranous enzyme, but the turnover rate was the same as the original proteoliposomes and the membranous enzyme. This disintegration of proteoliposomes by Chaps suggests the selective incorporation of the (Na+ + K+)-ATPase particle into the liposomes and the asymmetric orientation of the (Na+ + K+)-ATPase particle in the vesicle.
Analytical Biochemistry | 1981
Atsunobu Yoda; Shizuko Yoda
Abstract A method for the isolation of highly active membrane bound NaK-ATPase without detergents in quantity from the electric organ of the electric eel ( Electrophorus electricus ) is described. This method consists of the homogenation of electric organ with an isotonic solution containing sucrose, histidine, EDTA, and arginine, and of the separation of the higher active membrane fraction from the microsomal fraction by density gradient centrifugation. The enzyme has a specific activity of about 20 μmol Pi/min/mg at 37°C, and 13 μmol Pi/min/mg at 30°C. Although it is not as pure as the detergent-treated enzyme preparation based on the level of phosphorylated protein, ouabain binding, or sodium dodecyl sulfate-polyacrylamide gel electrophoresis, its enzyme activity is comparable to that of the purified enzymes. This preparation is very stable and is able to change its medium by Sephadex chromatography without any loss of enzyme activity and protein content. This preparation is also expected to keep the original characteristics as well as the enzyme in the tissue.
Current topics in membranes and transport | 1983
Atsunobu Yoda; Shizuko Yoda
Publisher Summary This chapter discusses the characteristics of the electric eel Na, K-ATPase phosphoprotein. The cleavage of ATP by the Na, K-ATPase proceeds through phosphorylated intermediates, the ADP- and K + -sensitive phosphoenzyrnes (E1P and E2P). In all Na, K-ATPase preparations known, E2P is the major component of the phosphorylated form, whereas E1P is the major component only in the presence of high concentrations of Na + or in an enzyme partially inhibited by N-ethylmaleimide (NEM). It is observed that the electric eel Na, K-ATPase prepared without any detergent produced mostly E1P in the presence of 100 mM Na + , but the microsomes of shark rectal gland, a fairly active form of Na, K-ATPase when prepared without detergent, produced mainly E2P. An increase in the Na concentration led to a higher E1P percentage in the shark enzyme. On the other hand, the eel enzyme formed mainly E2P in the presence of 10 mM Na + and did not show the oligomycin effect as in the shark enzyme in the presence of 100 m Na + . Therefore, it is concluded that the differences between eel and shark enzymes result from the different affinities of the two enzymes to Na + .
The Journal of Membrane Biology | 1990
Atsunobu Yoda; Shizuko Yoda
SummaryIn the NaK-ATPase proteoliposomes (PLs), the NaK-pump activity, Na+ uptake, and ATP hydrolysis were apparently enhanced by carbonyl cyanidem-chlorophenylhydrazone (CCCP) and other ionophores without ion gradients. These ionophore effects were not cation specific. Without ionophores, the PLs ATPase activity fell to its steady-state value within 3 sec at 15°C. This decrease in activity disappeared in the presence of CCCP. Since CCCP is believed to enhance proton mobility across the lipid bilayer and dissipate membrane potential (Vm), we postulated that aVm build-up partially inhibits the PLs by changing the conformation of the NaK-pump, and that CCCP eliminated this partial inhibition. Since this activation required extracellular K+ and high ATP concentration in the PLs, CCCP must affect the conversion between the phosphorylated forms of NaK-ATPase (EP); this step has been suggested by Goldschlegger et al. (1987) to be the voltage-sensitive step (J. Physiol. (London)387:331–355). Although cytoplasmic K+ accelerated the change of ADP-and K+-sensitive EP (E*P) to K+-sensitive ADP-insensitive EP (E2P), CCCP did not compete with cytoplasmic K+ when cytoplasmic Na+ was saturated. When the PLs were phosphorylated with 20 μm ATP and 20 μm palmitoyl CoA instead of with high concentration of ATP, CCCP increased the E*P content and decreased the ADP-sensitive K+-insensitive EP (E1P). The results described above suggest that CCCP affects the E1P to E*P change in the E1P→E*P→E2P conversion and that this reaction step is inhibited byVm.
Molecular Pharmacology | 1974
Atsunobu Yoda; Shizuko Yoda
Molecular Pharmacology | 1977
Atsunobu Yoda; Shizuko Yoda
Molecular Pharmacology | 1973
Atsunobu Yoda; Shizuko Yoda; Awni M. Sarrif
Molecular Pharmacology | 1973
Atsunobu Yoda; Shizuko Yoda
Molecular Pharmacology | 1975
Atsunobu Yoda; Shizuko Yoda
Molecular Pharmacology | 1978
Atsunobu Yoda; Shizuko Yoda